+574.3%
TWLO vs GSK
+87.7%
+486.6%
-90.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | -2.3% | -0.3% | -2.1% |
| 7D | -9.4% | -3.0% | -6.4% | -8.7% |
| 30D | -20.6% | +0.4% | -20.9% | -20.8% |
| 3M | -15.1% | -1.2% | -13.9% | -15.1% |
| 6M | -2.1% | +0.9% | -3.0% | -3.1% |
| YTD | +36.5% | +4.0% | +32.5% | +32.6% |
| 1Y | +61.5% | +7.3% | +54.2% | +55.4% |
| 3Y | +207.6% | +57.1% | +150.5% | +152.9% |
| 5Y | -35.9% | +43.0% | -78.8% | -46.3% |
| 10Y | +451.3% | +103.1% | +348.3% | +238.9% |
| All | +574.3% | +87.7% | +486.6% | +358.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling